Tilray Brands shares rise 2.40% premarket after forming strategic partnerships in Italy to broaden access to medical cannabis extracts.

Tilray Brands, Inc. rose 2.40% in premarket trading, driven by multiple strategic partnerships announced by its subsidiary Tilray Medical. The company formed a partnership with Molteni, an Italian pharmaceutical firm specializing in pain therapies and substance dependence, to broaden access to medical cannabis extracts in Italy. Additionally, Tilray Medical announced other partnerships aimed at increasing access to medical cannabis extracts, which likely contributed to the positive market sentiment.